Showing all 6 results
Pharma Leader Series: Top 26 Asthma & COPD Companies 2020-2030
The global asthma & COPD therapies market was valued at $36.21bn in 2018 and is projected to grow to $60.8bn...Full DetailsPUBLISHED: 17 February 2020The Global Respiratory Inhalers Market 2020-2030
Visiongain estimates that the global respiratory inhalers market reached $32.6bn in 2019 and will grow at a CAGR of 3.9%...Full DetailsPUBLISHED: 28 January 2020Pharma Leader Series: Top 55 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market 2020
Contract manufacturing represents the largest sector of the pharma outsourcing industry. Pharmaceutical companies have sought to take advantage of the...Full DetailsPUBLISHED: 16 January 2020Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market Forecast to 2029
The global anti-idiopathic pulmonary fibrosis drugs market is expected to grow at a CAGR of 16.7% in the first half...Full DetailsPUBLISHED: 26 November 2019Top 20 Global Respiratory Inhalers Manufacturers 2019
The global respiratory inhalers market is estimated to reach $38bn in 2023. In the respiratory Inhalers market the top three...Full DetailsPUBLISHED: 09 April 2019Global Asthma & COPD Therapies Market 2019-2029
The global asthma & COPD therapies market was valued at $32bn in 2018 and is projected to grow at a...Full DetailsPUBLISHED: 19 March 2019
